{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:48:22Z","timestamp":1791600502368,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"German Aerospace Center (DLR) and the Federal Ministry of Economic Affairs and Technology","award":["50WB0719\/WB0919 and WB1622, 50WB1931, RP1920"],"award-info":[{"award-number":["50WB0719\/WB0919 and WB1622, 50WB1931, RP1920"]}]},{"name":"Universit\u00e4tsklinik M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Secondary infections have been shown to complicate the clinical course and worsen the outcome of critically ill patients. Severe Coronavirus Disease 2019 (COVID-19) may be accompanied by a pronounced cytokine release, and immune competence of these patients towards most pathogenic antigens remains uncompromised early in the disease. Patients with bacterial sepsis also exhibit excessive cytokine release with systemic hyper-inflammation, however, typically\u00a0followed by an anti-inflammatory phase, causing immune paralysis. In a second hit immune response model, leukocyte activation capacity of severely ill patients with pneumonia caused by SARS-CoV-2 or by bacteria were compared upon ICU admission and at days 4 and 7 of the ICU stay. Blood cell count\u00a0and\u00a0release of the pro-inflammatory cytokines IL-2, IFN\u03b3 and TNF were assessed after whole-blood incubation with the potent immune stimulus pokeweed mitogen (PWM). For comparison, patients with bacterial sepsis not originating from pneumonia, and healthy volunteers were included. Lymphopenia and granulocytosis were less pronounced in COVID-19 patients compared to bacterial sepsis patients. After PWM stimulation, COVID-19 patients showed a reduced release of IFN\u03b3, while IL-2 levels were found similar and TNF levels were increased compared to healthy controls. Interestingly, concentrations of all three cytokines were significantly higher in samples from COVID-19 patients compared to samples from patients with bacterial infection. This fundamental difference in immune competence during a second hit between COVID-19 and sepsis patients may have implications for the selection of immune suppressive or enhancing therapies in personalized medicine.<\/jats:p>","DOI":"10.1038\/s41598-022-17368-9","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T10:02:59Z","timestamp":1663236179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["SARS-CoV-2 pneumonia and bacterial pneumonia patients differ in a second hit immune response model"],"prefix":"10.1038","volume":"12","author":[{"given":"Dominique","family":"Moser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Feuerecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Biere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Hoerl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustav","family":"Schelling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Chouk\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Woehrle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"17368_CR1","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/imr.12499","volume":"274","author":"MJ Delano","year":"2016","unstructured":"Delano, M. J. & Ward, P. A. The immune system\u2019s role in sepsis progression, resolution, and long-term outcome. Immunol. Rev. 274, 330\u2013353. https:\/\/doi.org\/10.1111\/imr.12499 (2016).","journal-title":"Immunol. Rev."},{"key":"17368_CR2","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1001\/jama.2016.2691","volume":"315","author":"LA van Vught","year":"2016","unstructured":"van Vught, L. A. et al. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA 315, 1469\u20131479. https:\/\/doi.org\/10.1001\/jama.2016.2691 (2016).","journal-title":"JAMA"},{"key":"17368_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fcimb.2017.00338","volume":"7","author":"L Jia","year":"2017","unstructured":"Jia, L. et al. Mechanisms of severe mortality-associated bacterial co-infections following influenza virus infection. Front. Cell. Infect. Microbiol. 7, 338. https:\/\/doi.org\/10.3389\/fcimb.2017.00338 (2017).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"17368_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506. https:\/\/doi.org\/10.1016\/s0140-6736(20)30183-5 (2020).","journal-title":"Lancet"},{"key":"17368_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/joim.13144","volume":"289","author":"YM Gao","year":"2021","unstructured":"Gao, Y. M., Xu, G., Wang, B. & Liu, B. C. Cytokine storm syndrome in coronavirus disease 2019: A narrative review. J. Intern. Med. 289, 147\u2013161. https:\/\/doi.org\/10.1111\/joim.13144 (2021).","journal-title":"J. Intern. Med."},{"key":"17368_CR6","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","volume":"11","author":"D Ragab","year":"2020","unstructured":"Ragab, D., Salah Eldin, H., Taeimah, M., Khattab, R. & Salem, R. The COVID-19 cytokine storm; What we know so far. Front. Immunol. 11, 1446. https:\/\/doi.org\/10.3389\/fimmu.2020.01446 (2020).","journal-title":"Front. Immunol."},{"key":"17368_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu, B., Huang, S. & Yin, L. The cytokine storm and COVID-19. J. Med. Virol. 93, 250\u2013256. https:\/\/doi.org\/10.1002\/jmv.26232 (2021).","journal-title":"J. Med. Virol."},{"key":"17368_CR8","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/jci137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen, G. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Investig. 130, 2620\u20132629. https:\/\/doi.org\/10.1172\/jci137244 (2020).","journal-title":"J. Clin. Investig."},{"key":"17368_CR9","doi-asserted-by":"publisher","first-page":"640644","DOI":"10.3389\/fimmu.2021.640644","volume":"12","author":"D Moser","year":"2021","unstructured":"Moser, D. et al. COVID-19 impairs immune response to Candida albicans. Front. Immunol. 12, 640644. https:\/\/doi.org\/10.3389\/fimmu.2021.640644 (2021).","journal-title":"Front. Immunol."},{"key":"17368_CR10","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/s41598-018-19976-w","volume":"8","author":"M Feuerecker","year":"2018","unstructured":"Feuerecker, M. et al. Early immune anergy towards recall antigens and mitogens in patients at onset of septic shock. Sci. Rep. 8, 1754. https:\/\/doi.org\/10.1038\/s41598-018-19976-w (2018).","journal-title":"Sci. Rep."},{"key":"17368_CR11","volume-title":"StatPearls (StatPearls Publishing Copyright \u00a9 2021","author":"RK Chakraborty","year":"2021","unstructured":"Chakraborty, R. K. & Burns, B. StatPearls (StatPearls Publishing Copyright \u00a9 2021 (StatPearls Publishing LLC, 2021)."},{"key":"17368_CR12","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3389\/fimmu.2019.01687","volume":"10","author":"A Assinger","year":"2019","unstructured":"Assinger, A., Schrottmaier, W. C., Salzmann, M. & Rayes, J. Platelets in sepsis: An update on experimental models and clinical data. Front. Immunol. 10, 1687. https:\/\/doi.org\/10.3389\/fimmu.2019.01687 (2019).","journal-title":"Front. Immunol."},{"key":"17368_CR13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/infdis\/jis383","volume":"206","author":"J Unsinger","year":"2012","unstructured":"Unsinger, J. et al. Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis. J. Infect. Dis. 206, 606\u2013616. https:\/\/doi.org\/10.1093\/infdis\/jis383 (2012).","journal-title":"J. Infect. Dis."},{"key":"17368_CR14","first-page":"426","volume":"81","author":"L Hamers","year":"2015","unstructured":"Hamers, L., Kox, M. & Pickkers, P. Sepsis-induced immunoparalysis: Mechanisms, markers, and treatment options. Minerva Anestesiol. 81, 426\u2013439 (2015).","journal-title":"Minerva Anestesiol."},{"key":"17368_CR15","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140289","author":"JG Wilson","year":"2020","unstructured":"Wilson, J. G. et al. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.140289 (2020).","journal-title":"JCI Insight"},{"key":"17368_CR16","doi-asserted-by":"publisher","first-page":"m3339","DOI":"10.1136\/bmj.m3339","volume":"370","author":"SR Knight","year":"2020","unstructured":"Knight, S. R. et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: Development and validation of the 4C Mortality Score. BMJ 370, m3339. https:\/\/doi.org\/10.1136\/bmj.m3339 (2020).","journal-title":"BMJ"},{"key":"17368_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s41232-020-00131-w","volume":"40","author":"R Otsuka","year":"2020","unstructured":"Otsuka, R. & Seino, K. I. Macrophage activation syndrome and COVID-19. Inflamm. Regener. 40, 19. https:\/\/doi.org\/10.1186\/s41232-020-00131-w (2020).","journal-title":"Inflamm. Regener."},{"key":"17368_CR18","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum, D. C. & June, C. H. Cytokine storm. N. Engl. J. Med. 383, 2255\u20132273. https:\/\/doi.org\/10.1056\/NEJMra2026131 (2020).","journal-title":"N. Engl. J. Med."},{"key":"17368_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/s1473-3099(13)70001-x","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss, R. S., Monneret, G. & Payen, D. Immunosuppression in sepsis: A novel understanding of the disorder and a new therapeutic approach. Lancet Infect. Dis. 13, 260\u2013268. https:\/\/doi.org\/10.1016\/s1473-3099(13)70001-x (2013).","journal-title":"Lancet Infect. Dis."},{"key":"17368_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/shk.0000000000000495","volume":"45","author":"T Rimmel\u00e9","year":"2016","unstructured":"Rimmel\u00e9, T. et al. Immune cell phenotype and function in sepsis. Shock 45, 282\u2013291. https:\/\/doi.org\/10.1097\/shk.0000000000000495 (2016).","journal-title":"Shock"},{"key":"17368_CR21","doi-asserted-by":"publisher","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","volume":"19","author":"D McGonagle","year":"2020","unstructured":"McGonagle, D., Sharif, K., O\u2019Regan, A. & Bridgewood, C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun. Rev. 19, 102537. https:\/\/doi.org\/10.1016\/j.autrev.2020.102537 (2020).","journal-title":"Autoimmun. Rev."},{"key":"17368_CR22","doi-asserted-by":"publisher","first-page":"7527953","DOI":"10.1155\/2020\/7527953","volume":"2020","author":"S Cicco","year":"2020","unstructured":"Cicco, S., Cicco, G., Racanelli, V. & Vacca, A. Neutrophil extracellular traps (NETs) and damage-associated molecular patterns (DAMPs): Two potential targets for COVID-19 treatment. Mediat. Inflamm. 2020, 7527953. https:\/\/doi.org\/10.1155\/2020\/7527953 (2020).","journal-title":"Mediat. Inflamm."},{"key":"17368_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000513198","volume":"27","author":"KP Mishra","year":"2020","unstructured":"Mishra, K. P., Singh, A. K. & Singh, S. B. Hyperinflammation and immune response generation in COVID-19. NeuroImmunoModulation 27, 80\u201386. https:\/\/doi.org\/10.1159\/000513198 (2020).","journal-title":"NeuroImmunoModulation"},{"key":"17368_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/path.4124","volume":"229","author":"LB Tolle","year":"2013","unstructured":"Tolle, L. B. & Standiford, T. J. Danger-associated molecular patterns (DAMPs) in acute lung injury. J. Pathol. 229, 145\u2013156. https:\/\/doi.org\/10.1002\/path.4124 (2013).","journal-title":"J. Pathol."},{"key":"17368_CR25","doi-asserted-by":"publisher","first-page":"e13404","DOI":"10.1111\/eci.13404","volume":"51","author":"S Jimeno","year":"2021","unstructured":"Jimeno, S. et al. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19. Eur. J. Clin. Invest. 51, e13404. https:\/\/doi.org\/10.1111\/eci.13404 (2021).","journal-title":"Eur. J. Clin. Invest."},{"key":"17368_CR26","doi-asserted-by":"publisher","first-page":"105036","DOI":"10.1016\/j.phrs.2020.105036","volume":"160","author":"X Li","year":"2020","unstructured":"Li, X. et al. Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019. Pharmacol. Res. 160, 105036. https:\/\/doi.org\/10.1016\/j.phrs.2020.105036 (2020).","journal-title":"Pharmacol. Res."},{"key":"17368_CR27","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","volume":"9","author":"H Han","year":"2020","unstructured":"Han, H. et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg. Microb. Infect. 9, 1123\u20131130. https:\/\/doi.org\/10.1080\/22221751.2020.1770129 (2020).","journal-title":"Emerg. Microb. Infect."},{"key":"17368_CR28","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1038\/s41467-020-17292-4","volume":"11","author":"S De Biasi","year":"2020","unstructured":"De Biasi, S. et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat. Commun. 11, 3434. https:\/\/doi.org\/10.1038\/s41467-020-17292-4 (2020).","journal-title":"Nat. Commun."},{"key":"17368_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jaci.2020.04.029","volume":"146","author":"S Trouillet-Assant","year":"2020","unstructured":"Trouillet-Assant, S. et al. Type I IFN immunoprofiling in COVID-19 patients. J. Allergy Clin. Immunol. 146, 206-208.e202. https:\/\/doi.org\/10.1016\/j.jaci.2020.04.029 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"17368_CR30","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.jiph.2020.07.001","volume":"13","author":"MA Chowdhury","year":"2020","unstructured":"Chowdhury, M. A., Hossain, N., Kashem, M. A., Shahid, M. A. & Alam, A. Immune response in COVID-19: A review. J. Infect. Public Health 13, 1619\u20131629. https:\/\/doi.org\/10.1016\/j.jiph.2020.07.001 (2020).","journal-title":"J. Infect. Public Health"},{"key":"17368_CR31","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/s2213-2600(20)30267-8","volume":"8","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: Challenges and opportunities. Lancet Respir. Med. 8, 822\u2013830. https:\/\/doi.org\/10.1016\/s2213-2600(20)30267-8 (2020).","journal-title":"Lancet Respir. Med."},{"key":"17368_CR32","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140329","author":"KE Remy","year":"2020","unstructured":"Remy, K. E. et al. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.140329 (2020).","journal-title":"JCI Insight"},{"key":"17368_CR33","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","volume":"26","author":"BJ Langford","year":"2020","unstructured":"Langford, B. J. et al. Bacterial co-infection and secondary infection in patients with COVID-19: A living rapid review and meta-analysis. Clin. Microbiol. Infect. 26, 1622\u20131629. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.016 (2020).","journal-title":"Clin. Microbiol. Infect."},{"key":"17368_CR34","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3949\/ccjm.87a.ccc015","volume":"87","author":"CP Wu","year":"2020","unstructured":"Wu, C. P., Adhi, F. & Highland, K. Recognition and management of respiratory co-infection and secondary bacterial pneumonia in patients with COVID-19. Clevel. Clin. J. Med. 87, 659\u2013663. https:\/\/doi.org\/10.3949\/ccjm.87a.ccc015 (2020).","journal-title":"Clevel. Clin. J. Med."},{"key":"17368_CR35","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/cid\/ciaa530","volume":"71","author":"TM Rawson","year":"2020","unstructured":"Rawson, T. M. et al. Bacterial and fungal coinfection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin. Microbiol. Infect. 71, 2459\u20132468. https:\/\/doi.org\/10.1093\/cid\/ciaa530 (2020).","journal-title":"Clin. Microbiol. Infect."},{"key":"17368_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","volume":"27","author":"C Garcia-Vidal","year":"2021","unstructured":"Garcia-Vidal, C. et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: A retrospective cohort study. Clin. Microbiol. Infect. 27, 83\u201388. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.041 (2021).","journal-title":"Clin. Microbiol. Infect."},{"key":"17368_CR37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1164\/rccm.202009-3400OC","volume":"203","author":"A Fekkar","year":"2021","unstructured":"Fekkar, A. et al. Occurrence of invasive pulmonary fungal infections in patients with severe COVID-19 admitted to the ICU. Am. J. Respir. Crit. Care Med. 203, 307\u2013317. https:\/\/doi.org\/10.1164\/rccm.202009-3400OC (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"17368_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03460-5","author":"M Maes","year":"2021","unstructured":"Maes, M. et al. Ventilator-associated pneumonia in critically ill patients with COVID-19. Crit. Care https:\/\/doi.org\/10.1186\/s13054-021-03460-5 (2021).","journal-title":"Crit. Care"},{"key":"17368_CR39","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1164\/rccm.202106-1354OC","volume":"204","author":"CO Pickens","year":"2021","unstructured":"Pickens, C. O. et al. Bacterial superinfection pneumonia in patients mechanically ventilated for COVID-19 pneumonia. Am. J. Respir. Crit. Care Med. 204, 921\u2013932. https:\/\/doi.org\/10.1164\/rccm.202106-1354OC (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"17368_CR40","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s00134-020-06323-9","volume":"47","author":"A Rouz\u00e9","year":"2021","unstructured":"Rouz\u00e9, A. et al. Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: A European multicenter cohort study. Intens. Care Med. 47, 188\u2013198. https:\/\/doi.org\/10.1007\/s00134-020-06323-9 (2021).","journal-title":"Intens. Care Med."},{"key":"17368_CR41","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.chest.2021.04.002","volume":"160","author":"G Grasselli","year":"2021","unstructured":"Grasselli, G. et al. Hospital-acquired infections in critically Ill patients With COVID-19. Chest 160, 454\u2013465. https:\/\/doi.org\/10.1016\/j.chest.2021.04.002 (2021).","journal-title":"Chest"},{"key":"17368_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cmi.2020.09.025","volume":"27","author":"TM Rawson","year":"2021","unstructured":"Rawson, T. M., Wilson, R. C. & Holmes, A. Understanding the role of bacterial and fungal infection in COVID-19. Clin. Microbiol. Infect. 27, 9\u201311. https:\/\/doi.org\/10.1016\/j.cmi.2020.09.025 (2021).","journal-title":"Clin. Microbiol. Infect."},{"key":"17368_CR43","doi-asserted-by":"publisher","first-page":"300060521106278","DOI":"10.1177\/03000605211062783","volume":"49","author":"J Zhang","year":"2021","unstructured":"Zhang, J. et al. Secondary bloodstream infection in critically ill patients with COVID-19. J. Int. Med. Res. 49, 3000605211062783. https:\/\/doi.org\/10.1177\/03000605211062783 (2021).","journal-title":"J. Int. Med. Res."},{"key":"17368_CR44","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s00134-020-06057-8","volume":"46","author":"MC Copin","year":"2020","unstructured":"Copin, M. C., Parmentier, E., Duburcq, T., Poissy, J. & Mathieu, D. Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection. Intens. Care Med. 46, 1124\u20131126. https:\/\/doi.org\/10.1007\/s00134-020-06057-8 (2020).","journal-title":"Intens. Care Med."},{"key":"17368_CR45","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann, M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 383, 120\u2013128. https:\/\/doi.org\/10.1056\/NEJMoa2015432 (2020).","journal-title":"N. Engl. J. Med."},{"key":"17368_CR46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/jof6020091","volume":"6","author":"A Arastehfar","year":"2020","unstructured":"Arastehfar, A. et al. COVID-19 associated pulmonary aspergillosis (CAPA)-from immunology to treatment. J. Fungi 6, 91. https:\/\/doi.org\/10.3390\/jof6020091 (2020).","journal-title":"J. Fungi"},{"key":"17368_CR47","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/myc.13096","volume":"63","author":"P Koehler","year":"2020","unstructured":"Koehler, P. et al. COVID-19 associated pulmonary aspergillosis. Mycoses 63, 528\u2013534. https:\/\/doi.org\/10.1111\/myc.13096 (2020).","journal-title":"Mycoses"},{"key":"17368_CR48","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jmii.2020.09.004","volume":"54","author":"CC Lai","year":"2021","unstructured":"Lai, C. C. & Yu, W. L. COVID-19 associated with pulmonary aspergillosis: A literature review. J. Microbiol. Immunol. Infect. 54, 46\u201353. https:\/\/doi.org\/10.1016\/j.jmii.2020.09.004 (2021).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"17368_CR49","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1186\/cc10332","volume":"15","author":"GP Otto","year":"2011","unstructured":"Otto, G. P. et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit. Care 15, R183. https:\/\/doi.org\/10.1186\/cc10332 (2011).","journal-title":"Crit. Care"},{"key":"17368_CR50","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.2741\/4547","volume":"22","author":"Y Zhuang","year":"2017","unstructured":"Zhuang, Y., Peng, H., Chen, Y., Zhou, S. & Chen, Y. Dynamic monitoring of monocyte HLA-DR expression for the diagnosis, prognosis, and prediction of sepsis. Front. Biosci. 22, 1344\u20131354. https:\/\/doi.org\/10.2741\/4547 (2017).","journal-title":"Front. Biosci."},{"key":"17368_CR51","doi-asserted-by":"publisher","first-page":"304","DOI":"10.5114\/ait.2021.108579","volume":"53","author":"K Pandey","year":"2021","unstructured":"Pandey, K., Malviya, D., Awasthi, N. P., Nathi, S. S. & Harjai, M. Comparison of neutrophil CD64 and monocytic HLA-DR with existing biomarkers for the diagnosis and prognosis of sepsis. Anaesthesiol. Intens. Therapy 53, 304\u2013311. https:\/\/doi.org\/10.5114\/ait.2021.108579 (2021).","journal-title":"Anaesthesiol. Intens. Therapy"},{"key":"17368_CR52","doi-asserted-by":"publisher","first-page":"103622","DOI":"10.1016\/j.ebiom.2021.103622","volume":"73","author":"B Bonnet","year":"2021","unstructured":"Bonnet, B. et al. Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation. EBioMedicine 73, 103622. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103622 (2021).","journal-title":"EBioMedicine"},{"key":"17368_CR53","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210582","author":"AJ Wilk","year":"2021","unstructured":"Wilk, A. J. et al. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20210582 (2021).","journal-title":"J. Exp. Med."},{"key":"17368_CR54","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jamainternmed.2016.2514","volume":"176","author":"F Bloos","year":"2016","unstructured":"Bloos, F. et al. Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock: A randomized clinical trial. JAMA Intern. Med. 176, 1266\u20131276. https:\/\/doi.org\/10.1001\/jamainternmed.2016.2514 (2016).","journal-title":"JAMA Intern. Med."},{"key":"17368_CR55","doi-asserted-by":"publisher","first-page":"e29806","DOI":"10.1371\/journal.pone.0029806","volume":"7","author":"I Bekeredjian-Ding","year":"2012","unstructured":"Bekeredjian-Ding, I., Foermer, S., Kirschning, C. J., Parcina, M. & Heeg, K. Poke weed mitogen requires Toll-like receptor ligands for proliferative activity in human and murine B lymphocytes. PLoS ONE 7, e29806. https:\/\/doi.org\/10.1371\/journal.pone.0029806 (2012).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17368-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T10:05:48Z","timestamp":1663236348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17368-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["17368"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-17368-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]},"assertion":[{"value":"11 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15485"}}